Senseonics Holdings Inc (SENS)
0.431
-0.01
(-2.93%)
USD |
NYAM |
May 28, 11:46
Senseonics Holdings Cash from Operations (Quarterly): -20.26M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -20.26M |
| December 31, 2023 | -15.07M |
| September 30, 2023 | -17.26M |
| June 30, 2023 | -17.98M |
| March 31, 2023 | -19.85M |
| December 31, 2022 | -17.39M |
| September 30, 2022 | -14.58M |
| June 30, 2022 | -14.18M |
| March 31, 2022 | -20.16M |
| December 31, 2021 | -11.80M |
| September 30, 2021 | -13.87M |
| June 30, 2021 | -14.15M |
| March 31, 2021 | -16.26M |
| December 31, 2020 | -8.248M |
| September 30, 2020 | -13.40M |
| June 30, 2020 | -16.73M |
| March 31, 2020 | -29.05M |
| December 31, 2019 | -34.56M |
| September 30, 2019 | -35.63M |
| Date | Value |
|---|---|
| June 30, 2019 | -35.70M |
| March 31, 2019 | -30.15M |
| December 31, 2018 | -23.67M |
| September 30, 2018 | -26.73M |
| June 30, 2018 | -19.87M |
| March 31, 2018 | -20.50M |
| December 31, 2017 | -16.29M |
| September 30, 2017 | -15.25M |
| June 30, 2017 | -12.58M |
| March 31, 2017 | -11.62M |
| December 31, 2016 | -10.22M |
| September 30, 2016 | -10.42M |
| June 30, 2016 | -9.947M |
| March 31, 2016 | -7.43M |
| September 30, 2015 | -0.0082M |
| June 30, 2015 | -0.0137M |
| March 31, 2015 | -0.0025M |
| December 31, 2014 | -0.0022M |
| September 30, 2014 | -0.0056M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-35.70M
Minimum
Jun 2019
-8.248M
Maximum
Dec 2020
-19.31M
Average
-17.00M
Median
Cash from Operations (Quarterly) Benchmarks
| Stereotaxis Inc | -2.346M |
| Biolase Inc | -5.938M |
| AVITA Medical Inc | -20.86M |
| Perspective Therapeutics Inc | 13.85M |
| Electromed Inc | 1.351M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 25.38M |
| Cash from Financing (Quarterly) | 10.03M |
| Free Cash Flow | -71.19M |
| Free Cash Flow Per Share (Quarterly) | -0.0335 |
| Free Cash Flow to Equity (Quarterly) | -31.28M |
| Free Cash Flow Yield | -27.67% |